Trials / Conditions / Porphyria Cutanea Tarda
Porphyria Cutanea Tarda
6 registered clinical trials studyying Porphyria Cutanea Tarda.
| Status | Trial | Sponsor | Phase |
|---|---|---|---|
| Completed | Harvoni Treatment Porphyria Cutanea Tarda NCT03118674 | Wake Forest University Health Sciences | Phase 2 |
| Unknown | Safety and Efficacy of Oral Deferasirox in Patients With Porphyria Cutanea Tarda NCT01284946 | Assistance Publique - Hôpitaux de Paris | Phase 2 |
| Completed | Pilot Trial of Deferasirox in the Treatment of Porphyria Cutanea Tarda NCT00599326 | University of Texas Southwestern Medical Center | Phase 3 |
| Completed | Hydroxychloroquine and Phlebotomy for Treating Porphyria Cutanea Tarda NCT01573754 | The University of Texas Medical Branch, Galveston | Phase 2 |
| Completed | Study of the Pathogenesis of Porphyria Cutanea Tarda NCT00005103 | National Center for Research Resources (NCRR) | — |
| Completed | Risk Factors of Porphyria Cutanea Tarda (PCT) NCT00213772 | University Hospital, Strasbourg, France | — |